• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素类物质(如大麻二酚)对慢性不可预知温和应激模型大鼠的抗抑郁作用

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

机构信息

Pharmacology Department, School of Pharmacy, University of Mississippi, University, MS 38677, USA.

出版信息

Pharmacol Biochem Behav. 2010 Jun;95(4):434-42. doi: 10.1016/j.pbb.2010.03.004. Epub 2010 Mar 21.

DOI:10.1016/j.pbb.2010.03.004
PMID:20332000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2866040/
Abstract

The antidepressant action of cannabis as well as the interaction between antidepressants and the endocannabinoid system has been reported. This study was conducted to assess the antidepressant-like activity of Delta(9)-THC and other cannabinoids. Cannabinoids were initially evaluated in the mouse tetrad assay to determine doses that do not induce hypothermia or catalepsy. The automated mouse forced swim (FST) and tail suspension (TST) tests were used to determine antidepressant action. At doses lacking hypothermic and cataleptic effects (1.25, 2.5, and 5 mg/kg, i.p.), both Delta(9)-THC and Delta(8)-THC showed a U-shaped dose response with only Delta(9)-THC showing significant antidepressant-like effects at 2.5 mg/kg (p<0.05) in the FST. The cannabinoids cannabigerol (CBG) and cannabinol (CBN) did not produce antidepressant-like actions up to 80 mg/kg in the mouse FST, while cannabichromene (CBC) and cannabidiol (CBD) exhibited significant effect at 20 and 200mg/kg, respectively (p<0.01). The antidepressant-like action of Delta(9)-THC and CBC was further confirmed in the TST. Delta(9)-THC exhibited the same U-shaped dose response with significant antidepressant-like action at 2.5 mg/kg (p<0.05) while CBC resulted in a significant dose-dependent decrease in immobility at 40 and 80 mg/kg doses (p<0.01). Results of this study show that Delta(9)-THC and other cannabinoids exert antidepressant-like actions, and thus may contribute to the overall mood-elevating properties of cannabis.

摘要

大麻的抗抑郁作用以及抗抑郁药与内源性大麻素系统之间的相互作用已经有报道。本研究旨在评估Δ9-四氢大麻酚和其他大麻素的抗抑郁样活性。大麻素最初在小鼠四联测试中进行评估,以确定不引起体温过低或僵住的剂量。自动小鼠强迫游泳(FST)和悬尾(TST)测试用于确定抗抑郁作用。在缺乏体温过低和僵住作用的剂量下(1.25、2.5 和 5mg/kg,ip),Δ9-THC 和 Δ8-THC 均表现出 U 形剂量反应,只有 Δ9-THC 在 FST 中在 2.5mg/kg 时表现出显著的抗抑郁样作用(p<0.05)。大麻素大麻萜酚(CBG)和大麻酚(CBN)在小鼠 FST 中高达 80mg/kg 时没有产生抗抑郁样作用,而大麻色烯(CBC)和大麻二酚(CBD)在 20 和 200mg/kg 时分别表现出显著作用(p<0.01)。在 TST 中进一步证实了 Δ9-THC 和 CBC 的抗抑郁样作用。Δ9-THC 表现出相同的 U 形剂量反应,在 2.5mg/kg 时具有显著的抗抑郁样作用(p<0.05),而 CBC 导致在 40 和 80mg/kg 剂量时运动性显著剂量依赖性降低(p<0.01)。本研究结果表明,Δ9-THC 和其他大麻素具有抗抑郁样作用,因此可能有助于大麻的整体情绪提升特性。

相似文献

1
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.大麻素类物质(如大麻二酚)对慢性不可预知温和应激模型大鼠的抗抑郁作用
Pharmacol Biochem Behav. 2010 Jun;95(4):434-42. doi: 10.1016/j.pbb.2010.03.004. Epub 2010 Mar 21.
2
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.大麻天然成分大麻色烯的药理学评价及其与Δ(9)-四氢大麻酚的调节作用。
Drug Alcohol Depend. 2010 Nov 1;112(1-2):126-33. doi: 10.1016/j.drugalcdep.2010.05.019.
3
Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.评价选定的次要大麻素和萜烯类化合物在小鼠体内的拟大麻素作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 8;132:110984. doi: 10.1016/j.pnpbp.2024.110984. Epub 2024 Feb 27.
4
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.大麻二酚类似物 HU-502 和 HU-556 诱导的行为效应。
Behav Pharmacol. 2023 Jun 1;34(4):213-224. doi: 10.1097/FBP.0000000000000727. Epub 2023 May 10.
5
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.一种大麻衍生的“全谱”口服大麻素产品的药代动力学和药效学,该产品中大麻二酚与大麻二酚酸以及Δ9-四氢大麻酚与Δ9-四氢大麻酚酸的比例为1:1:一项双盲、安慰剂对照、受试者内人体实验室研究。
Cannabis Cannabinoid Res. 2025 Apr;10(2):e299-e313. doi: 10.1089/can.2024.0187. Epub 2025 Mar 5.
6
[Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)].液相色谱-四极杆飞行时间质谱法(LC-Q-TOF-MS)测定大麻中的11种大麻素
Yakugaku Zasshi. 2023;143(4):411-418. doi: 10.1248/yakushi.22-00198.
7
Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.健康人体受试者中,急性口服Δ9-四氢大麻酚和标准化大麻提取物与精神运动表现的关系。
Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):284-92. doi: 10.1007/s00406-009-0868-5. Epub 2009 Feb 17.
8
Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.大麻其他成分对四氢大麻酚致僵效应的抑制作用
J Pharm Pharmacol. 1988 Feb;40(2):132-4. doi: 10.1111/j.2042-7158.1988.tb05198.x.
9
Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.大麻素受体1结合活性及大麻烟雾与蒸汽的定量分析
Chem Pharm Bull (Tokyo). 2010 Feb;58(2):201-7. doi: 10.1248/cpb.58.201.
10
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.口服 Δ9-四氢大麻酚(THC)和大麻二酚(CBD)在雄性和雌性大鼠中的大麻素四联体效应:性别、剂量效应和时间过程评估。
Psychopharmacology (Berl). 2022 May;239(5):1397-1408. doi: 10.1007/s00213-021-05995-5. Epub 2021 Oct 15.

引用本文的文献

1
Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats.六氢大麻酚:Wistar大鼠的药代动力学、全身毒性及急性行为效应
Int J Neuropsychopharmacol. 2025 Aug 1;28(8). doi: 10.1093/ijnp/pyaf041.
2
Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations.大麻二酚,一种治疗重度抑郁症的关键非精神活性植物大麻素:计算机模拟和体内实验探索
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 13. doi: 10.1007/s00210-025-04236-2.
3
Pharmacokinetics of Non-Psychotropic Phytocannabinoids.

本文引用的文献

1
Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa.来自高效力大麻的大麻二酚色满酮衍生物的结构测定和绝对构型
Tetrahedron Lett. 2008 Oct 13;49(42):6050-6053. doi: 10.1016/j.tetlet.2008.07.178.
2
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.在内脏痛觉过敏的醋酸模型中对常见植物大麻素的评估。
Drug Alcohol Depend. 2009 Nov 1;105(1-2):42-7. doi: 10.1016/j.drugalcdep.2009.06.009. Epub 2009 Aug 12.
3
Biologically active cannabinoids from high-potency Cannabis sativa.
非精神活性植物大麻素的药代动力学
Pharmaceutics. 2025 Feb 12;17(2):236. doi: 10.3390/pharmaceutics17020236.
4
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation.大麻素补充剂的肾脏结局及其他不良反应
Nutrients. 2024 Dec 27;17(1):59. doi: 10.3390/nu17010059.
5
Antidepressant-like Effects of L. Extract in an Lipopolysaccharide Model: Modulation of Mast Cell Activation in Deep Cervical Lymph Nodes and Dura Mater.L.提取物在脂多糖模型中的抗抑郁样作用:对颈深部淋巴结和硬脑膜中肥大细胞活化的调节
Pharmaceuticals (Basel). 2024 Oct 21;17(10):1409. doi: 10.3390/ph17101409.
6
as an Herbal Ingredient: Problems and Prospects.作为草药成分:问题与展望。
Molecules. 2024 Jul 30;29(15):3605. doi: 10.3390/molecules29153605.
7
Depressive symptoms predict cannabis vaping initiation among young adults.抑郁症状预测年轻人开始吸食大麻电子烟。
Drug Alcohol Depend. 2024 Sep 1;262:111397. doi: 10.1016/j.drugalcdep.2024.111397. Epub 2024 Jul 14.
8
In Vitro and In Vivo Anti-Inflammatory and Antidepressant-like Effects of L. Extracts.L.提取物的体外和体内抗炎及抗抑郁样作用。
Plants (Basel). 2024 Jun 12;13(12):1619. doi: 10.3390/plants13121619.
9
Cannabigerol-A useful agent restoring the muscular phospholipids milieu in obese and insulin-resistant Wistar rats?大麻二酚——一种有助于恢复肥胖和胰岛素抵抗的Wistar大鼠肌肉磷脂环境的有效物质?
Front Mol Biosci. 2024 Jun 11;11:1401558. doi: 10.3389/fmolb.2024.1401558. eCollection 2024.
10
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.对天然和合成大麻素的滥用、依赖性及相关安全风险的批判性评估。
Front Psychiatry. 2024 Jun 10;15:1322434. doi: 10.3389/fpsyt.2024.1322434. eCollection 2024.
高浓度大麻中的生物活性大麻素。
J Nat Prod. 2009 May 22;72(5):906-11. doi: 10.1021/np900067k.
4
Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis.使用大麻会影响双相情感障碍的治疗结果吗?一项纵向分析。
J Nerv Ment Dis. 2009 Jan;197(1):35-40. doi: 10.1097/NMD.0b013e31819292a6.
5
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders.有和没有大麻使用障碍的双相情感障碍青少年的神经解剖学比较。
J Child Adolesc Psychopharmacol. 2008 Dec;18(6):557-63. doi: 10.1089/cap.2008.033.
6
Non-cannabinoid constituents from a high potency Cannabis sativa variety.来自高药效大麻品种的非大麻素成分。
Phytochemistry. 2008 Oct;69(14):2627-33. doi: 10.1016/j.phytochem.2008.07.010. Epub 2008 Sep 4.
7
Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory.北领地阿纳姆地三个原住民社区中大量使用大麻与抑郁症状的关系
Med J Aust. 2008 May 19;188(10):605-8. doi: 10.5694/j.1326-5377.2008.tb01803.x.
8
Cannabis and psychiatric disorders: it is not only addiction.大麻与精神疾病:问题不止于成瘾。
Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x.
9
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report.患有抑郁症的女性血清内源性大麻素含量发生改变:一项初步报告。
Pharmacopsychiatry. 2008 Mar;41(2):48-53. doi: 10.1055/s-2007-993211.
10
Cannabinoid ester constituents from high-potency Cannabis sativa.来自高效能大麻的大麻素酯成分。
J Nat Prod. 2008 Apr;71(4):536-42. doi: 10.1021/np070454a. Epub 2008 Feb 28.